Last updated on April 24, 2014 at 0:08 EDT

Latest Karo Bio Stories

2013-07-09 08:22:14

AMSTERDAM, July 9, 2013 /PRNewswire/ -- Comprehensive and relevant chemistry and bioactivity related content reduces research timescales and supports rapid user adoption Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical and medical information products and services, today announced that Karo Bio [http://www.karobio.com ], a developer of innovative drugs for large medical needs, has started to use Reaxys...

2008-10-31 12:00:32

Karo Bio, a drug discovery and development company, has successfully completed a 10-week Phase IIb study with eprotirome given to dyslipidemia patients undergoing treatment with the cholesterol absorption inhibitor ezetimibe. Eprotirome induced a statistically significant and clinically relevant lowering of serum low-density lipoprotein (LDL)-cholesterol, triglycerides and lipoprotein(a) and was safe and well tolerated. Data show that eprotirome in combination with ezetimibe can become an...